Humacyte annual operating expenses
2020
2021
2022
2023
2024
2025
Humacyte Operating Expenses Growth & History (HUMA)
Humacyte's operating expenses was $110.2M for fiscal 2025.
View full Humacyte company overviewHumacyte annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $110.2M | −$4.2M | −3.69% |
| 2024 | 2024-12-31 | $114.4M | $14.4M | +14.34% |
| 2023 | 2023-12-31 | $100.0M | $13.9M | +16.14% |
| 2022 | 2022-12-31 | $86.1M | $3.7M | +4.45% |
| 2021 | 2021-12-31 | $82.5M | $16.4M | +24.78% |
| 2020 | 2020-12-31 | $66.1M | — | — |
Humacyte quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $27.4M | −$2.6M | −8.75% |
| Q1 2026 | 2026-03-31 | $29.4M | $5.7M | +24.17% |
| Q4 2025 | 2025-12-31 | $31.3M | $3.2M | +11.45% |
| Q3 2025 | 2025-09-30 | $25.1M | −$5.1M | −16.84% |
| Q2 2025 | 2025-06-30 | $30.0M | $529,000 | +1.79% |
| Q1 2025 | 2025-03-31 | $23.7M | −$2.9M | −10.82% |
| Q4 2024 | 2024-12-31 | $28.1M | $1.9M | +7.28% |
| Q3 2024 | 2024-09-30 | $30.2M | $5.6M | +22.79% |
| Q2 2024 | 2024-06-30 | $29.5M | $2.8M | +10.36% |
| Q1 2024 | 2024-03-31 | $26.6M | $4.1M | +18.06% |
| Q4 2023 | 2023-12-31 | $26.2M | $5.4M | +25.94% |
| Q3 2023 | 2023-09-30 | $24.6M | $1.1M | +4.66% |
| Q2 2023 | 2023-06-30 | $26.7M | $6.9M | +34.79% |
| Q1 2023 | 2023-03-31 | $22.5M | $516,000 | +2.35% |
| Q4 2022 | 2022-12-31 | $20.8M | −$1.0M | −4.65% |
| Q3 2022 | 2022-09-30 | $23.5M | $2.7M | +13.19% |
| Q2 2022 | 2022-06-30 | $19.8M | −$127,000 | −0.64% |
| Q1 2022 | 2022-03-31 | $22.0M | $2.1M | +10.40% |
| Q4 2021 | 2021-12-31 | $21.8M | — | — |
| Q3 2021 | 2021-09-30 | $20.8M | $2.7M | +14.66% |
| Q2 2021 | 2021-06-30 | $20.0M | — | — |
| Q1 2021 | 2021-03-31 | $19.9M | — | — |
| Q3 2020 | 2020-09-30 | $18.1M | — | — |
Humacyte operating expenses trends
Over the last five fiscal years, Humacyte's operating expenses increased from $66.1M to $110.2M, a change of $44.1M. The latest reported quarter, Q2 2026, shows $27.4M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Humacyte source filings ↗